title: Increased transvascular lipoprotein transport in diabetes: association with albuminuria and systolic hypertension.
abstract: BACKGROUND
  Diabetes is associated with a highly increased risk of atherosclerosis, especially if hypertension or albuminuria is present.
  
  
  OBJECTIVE
  We hypothesized that the increased transvascular lipoprotein transport in diabetes may be further accelerated if hypertension or albuminuria is present, possibly explaining increased intimal lipoprotein accumulation and thus atherosclerosis.
  
  
  METHODS
  The study was cross-sectional and was performed in 1999-2002.
  
  
  METHODS
  The study took place in the referral center.
  
  
  METHODS
  The patients included 60 with diabetes mellitus (27 with type 1 diabetes and 33 with type 2 diabetes) and 42 healthy controls. All were randomly recruited.
  
  
  METHODS
  We used an in vivo method for measurement of transvascular transport of low-density lipoprotein (LDL). Autologous 131I-LDL was reinjected iv, and the 1-h fractional escape rate was taken as an index of transvascular transport.
  
  
  RESULTS
  Transvascular LDL transport was 1.8 (1.6-2.0), 2.3 (2.0-2.6), and 2.6 (1.3-4.0)%/[h x (liter/m2)] in healthy controls, diabetic controls, and diabetes patients with systolic hypertension or albuminuria, respectively (P = 0.013; F = 4.5; df =2; ANOVA). These differences most likely were not caused by altered hepatic LDL receptor expression, glycosylation of LDL, small LDL size, or medicine use.
  
  
  CONCLUSIONS
  Transvascular LDL transport is increased in patients with diabetes mellitus, especially if systolic hypertension or albuminuria is present. Accordingly, lipoprotein flux into the arterial wall could be increased in these patients, possibly explaining accelerated development of atherosclerosis.
authors.affiliation: Department of Nephrology and Endocrinology P, The National University Hospital, Copenhagen, Denmark. jsje@c.dk
authors.forename: Jan Skov
authors.initials: JS
authors.lastname: Jensen
authors.forename: Bo
authors.initials: B
authors.lastname: Feldt-Rasmussen
authors.forename: Knut
authors.initials: K
authors.lastname: Borch-Johnsen
authors.forename: Kurt Svarre
authors.initials: KS
authors.lastname: Jensen
authors.forename: Børge Grønne
authors.initials: BG
authors.lastname: Nordestgaard
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000419:Albuminuria / Q000150:complications / Q000453:epidemiology / Q000378:metabolism*; D001161:Arteriosclerosis / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism; D001794:Blood Pressure; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000453:epidemiology / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000453:epidemiology / Q000378:metabolism*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000453:epidemiology / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010316:Particle Size; D011973:Receptors, LDL / Q000737:chemistry / Q000378:metabolism*; D012307:Risk Factors
chemical_list: D011973:Receptors, LDL